Pulmonx Corporation LUNG
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.08M | -13.65M | -10.43M | -13.96M | -15.17M |
| Total Depreciation and Amortization | 222.00K | 120.00K | 331.00K | 146.00K | 299.00K |
| Total Amortization of Deferred Charges | 129.00K | 146.00K | -85.00K | 114.00K | 13.00K |
| Total Other Non-Cash Items | 4.26M | 4.87M | 4.78M | 5.66M | 6.29M |
| Change in Net Operating Assets | 258.00K | -1.58M | -1.68M | -128.00K | 4.67M |
| Cash from Operations | -5.21M | -10.10M | -7.08M | -8.16M | -3.91M |
| Capital Expenditure | -1.00K | -9.00K | -13.00K | -89.00K | -49.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 8.80M | 5.52M |
| Cash from Investing | -1.00K | -9.00K | -13.00K | 8.71M | 5.47M |
| Total Debt Issued | 0.00 | 38.79M | -- | -- | -- |
| Total Debt Repaid | -53.00K | -37.00M | -51.00K | -1.00K | -48.00K |
| Issuance of Common Stock | 0.00 | 241.00K | 106.00K | 205.00K | 28.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -460.00K | -- | 0.00 | -23.00K | -47.00K |
| Cash from Financing | -513.00K | 2.03M | 55.00K | 181.00K | -67.00K |
| Foreign Exchange rate Adjustments | 1.00K | -100.00K | 241.00K | 355.00K | -583.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.73M | -8.18M | -6.80M | 1.09M | 913.00K |